Lexington Biosciences Inc. (LXGTF)

[StockBro75]

LXGTF HeartSentry monitor first in class for measuring endothelial function and thereby diagnosing heart disease and stroke risk: "Lexington BioSciences has developed HeartSentry as a first-in-class device for the personalized measurement and monitoring of vascular health to identify cardiovascular disease at its earliest stages.

HeartSentry has been extensively tested to measure the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke, the two leading causes of death worldwide with over 17.5 million deaths each year. *